IDMI, @ $2.45, among other immunotherapy stocks(CEGE, NWBO, FVRL) soared after FDA gave reccomendation of approval for provenge in March of 2007. 5 days later on april 4 2007 IDMI reached $10.00 and an all-time high of 10.75 at the end of that month.
If DNDN passes the benchmark for statistical significance that basically means ultimate approval within 6 months. This will be a HUGE event and will be covered by news outlets all across the world, some will even report it as possible "cure" for cancer which would add to the frenzy. This will force the FDA to have a paradigm shift in regards to immunotherapy and its going to lead to more investment in biotech stocks. Their will be hundreds of thousands of google searches looking up "Immunotherapy" "what is immunotherapy?".
DNDN reaching SS will open the door for IDMI FDA approval and will bring many new investors driving up the stock price of IDMI, this company is the next in line for FDA approval.
I have read speculation that buy-out could depend on stock price at the time of sale. Is it possible that this thing jumps up to $7-8 dollars after DNDN event and thereby raising the final sale price to maybe $15 or $20? I hope so, I am anxiously awaiting results from DNDN's impact study.
btw I bought this stock because i heard the CEO of this company went to provenge rallies and told some provenge ralliers that he wants to see provenge approved because his company uses the same technology and this would validate Junovan and the field of immunotherapy. I have been long ever since. By knickerbocker on IDMI Yahoo mb.
